Drug Therapy of Apparent Treatment-Resistant Hypertension: Focus on Mineralocorticoid Receptor Antagonists

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Drugs

• Publication date

  2015-03-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s40265-015-0372-3PMID 25787734
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The impact of sodium and potassium on hypertension risk.

  2014cited by this paper
• Refining calcium test for diagnosis of medullary thyroid cancer: cutoffs, procedures and safety

  2014cited by this paper
• Role of aldosterone blockade in resistant hypertension.

  2014cited by this paper
• Proceedings from Duke resistant hypertension think tank.

  2014influential reference
• Comparison of agents that affect aldosterone action.

  2014cited by this paper
• Guidelines for the management of arterial hypertension

  2014influential reference
• Mechanism of salt-sensitive hypertension: focus on adrenal and sympathetic nervous systems.

  2014cited by this paper
• Increased aldosterone: mechanism of hypertension in obesity.

  2014cited by this paper
• 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).

  2014cited by this paper
• SYMPLICITY HTN 3: The death knell for renal denervation in hypertension?

  2014cited by this paper
• Resistant hypertension: a review of diagnosis and management.

  2014influential reference
• Prediction and management of hyperkalemia across the spectrum of chronic kidney disease.

  2014cited by this paper
• Aldosterone blockade in chronic kidney disease.

  2014influential reference
• Renin–Angiotensin System Blocking Drugs

  2014cited by this paper
• Renal nerve ablation for resistant hypertension: how did we get here, present status, and future directions.

  2014cited by this paper
• The prevalence, incidence, prognosis, and associated conditions of resistant hypertension.

  2014influential reference
• Renal Denervation in the Treatment of Hypertension

  2013cited by this paper
• New drug therapies interfering with the renin–angiotensin–aldosterone system for resistant hypertension

  2013cited by this paper
• Hypoadiponectinemia and aldosterone excess are associated with lack of blood pressure control in subjects with resistant hypertension

  2013cited by this paper
• Effectiveness of the direct renin inhibitor, aliskiren, in patients with resistant hypertension.

  2013influential reference
• Prevalence and prognostic role of resistant hypertension in chronic kidney disease patients.

  2013cited by this paper
• Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial.

  2013cited by this paper
• The contributions of unhealthy lifestyle factors to apparent resistant hypertension: findings from the Reasons for Geographic And Racial Differences in Stroke (REGARDS) study

  2013cited by this paper
• Obesity‐Related Hypertension: Pathogenesis, Cardiovascular Risk, and Treatment

  2013cited by this paper
• Can Diabetes Be Surgically Cured? Long-Term Metabolic Effects of Bariatric Surgery in Obese Patients with Type 2 Diabetes Mellitus

  2013cited by this paper
• Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension.

  2013cited by this paper
• Study of Aldosterone Synthase Inhibition as an Add‐On Therapy in Resistant Hypertension

  2013cited by this paper
• Self-Measured Blood Pressure Monitoring in the Management of Hypertension

  2013cited by this paper
• Metabolic syndrome, hypertension, and diabetes mellitus after gastric banding: the role of aging and of duration of obesity.

  2013cited by this paper
• Management of patients with resistant hypertension: current treatment options

  2013cited by this paper
• High-circulating leptin levels are associated with increased blood pressure in uncontrolled resistant hypertension

  2013cited by this paper
• Combination Therapy in Hypertension

  2013influential reference
• Precise assessment of noncompliance with the antihypertensive therapy in patients with resistant hypertension using toxicological serum analysis

  2013cited by this paper
• Resistant hypertension? Assessment of adherence by toxicological urine analysis

  2013cited by this paper
• Low dose spironolactone reduces blood pressure in patients with resistant hypertension and type 2 diabetes mellitus: a double blind randomized clinical trial

  2013cited by this paper
• Resistant hypertension and aldosterone: an update.

  2012cited by this paper
• Relationship of Resistant Hypertension and Treatment Outcomes With Total Arterial Compliance in a Predominantly African American Hypertensive Cohort

  2012cited by this paper
• The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury: systematic review and meta-analysis

  2012cited by this paper
• The Association Between Medication Adherence and Treatment Intensification With Blood Pressure Control in Resistant Hypertension

  2012cited by this paper
• Notice

  2012cited by this paper
• Resistant hypertension, obstructive sleep apnoea and aldosterone

  2012cited by this paper
• Mineralocorticoid receptor-associated hypertension and its organ damage: clinical relevance for resistant hypertension.

  2012cited by this paper
• Key advances in antihypertensive treatment

  2012influential reference
• Addition of Spironolactone in Patients With Resistant Arterial Hypertension (ASPIRANT): A Randomized, Double-Blind, Placebo-Controlled Trial

  2011cited by this paper
• Obstructive Sleep Apnea: The Most Common Secondary Cause of Hypertension Associated With Resistant Hypertension

  2011cited by this paper
• Catheter-Based Renal Sympathetic Denervation for Resistant Hypertension: Durability of Blood Pressure Reduction Out to 24 Months

  2011cited by this paper
• Efficacy of low dose spironolactone in chronic kidney disease with resistant hypertension.

  2011cited by this paper
• Clinical Features of 8295 Patients With Resistant Hypertension Classified on the Basis of Ambulatory Blood Pressure Monitoring

  2011cited by this paper
• Management of High Blood Pressure in Blacks: An Update of the International Society on Hypertension in Blacks Consensus Statement

  2011cited by this paper
• Effects of a Novel Aldosterone Synthase Inhibitor for Treatment of Primary Hypertension: Results of a Randomized, Double-Blind, Placebo- and Active-Controlled Phase 2 Trial

  2011cited by this paper
• Renal sympathetic denervation in patients with treatment- resistant hypertension (The Symplicity HTN-2 Trial): a randomized controlled trial

  2011cited by this paper
• 50 Years of Thiazides: Should Thiazide Diuretics Be Considered Third-Line Hypertension Treatment?

  2011cited by this paper
• Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial

  2010cited by this paper
• Aldosterone Synthase Inhibition With LCI699: A Proof-of-Concept Study in Patients With Primary Aldosteronism

  2010cited by this paper
• Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement.

  2010cited by this paper
• Rapid Reversal of Left Ventricular Hypertrophy and Intracardiac Volume Overload in Patients With Resistant Hypertension and Hyperaldosteronism: A Prospective Clinical Study

  2010cited by this paper
• Efficacy of Spironolactone Therapy in Patients With True Resistant Hypertension

  2010cited by this paper
• Prevalence and trends in obesity among US adults, 1999-2008.

  2010cited by this paper
• Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.

  2010cited by this paper
• Renewed Interest in Chlorthalidone: Evidence From the Veterans Health Administration

  2010cited by this paper
• The L-, N-, and T-type triple calcium channel blocker benidipine acts as an antagonist of mineralocorticoid receptor, a member of nuclear receptor family.

  2010cited by this paper
• Management of resistant arterial hypertension: role of spironolactone versus double blockade of the renin–angiotensin–aldosterone system

  2010cited by this paper
• Effects of dietary sodium reduction on blood pressure in patients with resistant hypertension

  2010cited by this paper
• Effects of Dietary Sodium Reduction on Blood Pressure in Subjects With Resistant Hypertension: Results From a Randomized Trial

  2010cited by this paper
• Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment.

  2010cited by this paper
• Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients

  2009cited by this paper
• Use of diuretics in patients with hypertension.

  2009cited by this paper
• Resistant Hypertension: Diagnosis, Evaluation, and Treatment: A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research

  2009cited by this paper
• Effects of Dietary Sodium Reduction on Blood Pressure in Subjects With Resistant Hypertension: Results From a Randomized Trial

  2009cited by this paper
• Aldosterone-receptor antagonism in hypertension

  2009cited by this paper
• Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.

  2009cited by this paper
• Catheter-based renal sympathetic denervation for resistant hypertension : A multicenter safety and proof-of-principle cohort study

  2009cited by this paper
• Spironolactone Reduces Severity of Obstructive Sleep Apnea in Patients with Resistant Hypertension: a Preliminary Report

  2009cited by this paper
• Obesity, sleep apnea, aldosterone, and hypertension

  2008cited by this paper
• Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.

  2008cited by this paper
• Resistant Hypertension: Diagnosis, Evaluation, and Treatment A the the for High

  2008cited by this paper
• Relation of Dietary Salt and Aldosterone to Urinary Protein Excretion in Subjects With Resistant Hypertension

  2008cited by this paper
• A Number of Marketed Dihydropyridine Calcium Channel Blockers Have Mineralocorticoid Receptor Antagonist Activity

  2008cited by this paper
• Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

  2008cited by this paper
• Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion.

  2008cited by this paper
• Prognostic influence of office and ambulatory blood pressures in resistant hypertension.

  2008cited by this paper
• Effect of Spironolactone on Blood Pressure in Subjects With Resistant Hypertension

  2007cited by this paper
• Low-dose spironolactone in the management of resistant hypertension: a surveillance study

  2007cited by this paper
• 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

  2007cited by this paper
• Resistant hypertension and aldosteronism

  2007cited by this paper
• Amiloride 10 mg is less effective than spironolactone 25 mg in patients with hypertension resistant to a multidrug regime including an angiotensin-blocking agent.

  2007cited by this paper
• Erratum: Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension and of the European Society of Cardiology (Journal of Hypertension (2007) 25, (1105-1187))

  2007cited by this paper
• 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension.

  2007cited by this paper
• Cross-sectional relations of serum aldosterone and urine sodium excretion to urinary albumin excretion in a community-based sample.

  2006cited by this paper
• Comparative Antihypertensive Effects of Hydrochlorothiazide and Chlorthalidone on Ambulatory and Office Blood Pressure

  2006cited by this paper
• Efficacy of add-on aldosterone receptor blocker in uncontrolled hypertension.

  2006cited by this paper
• Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension.

  2005cited by this paper
• Improvement in Blood Pressure With Inhibition of the Epithelial Sodium Channel in Blacks With Hypertension

  2005cited by this paper
• Nongenomic Effects of Aldosterone in the Human Heart: Interaction With Angiotensin II

  2005cited by this paper
• Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension.

  2005cited by this paper
• Elective single-embryo transfer versus double-embryo transfer in in vitro fertilization

  2004cited by this paper
• Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery.

  2004cited by this paper
• Effect of spironolactone on cardiac sympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy.

  2003cited by this paper
• A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

  2003cited by this paper
• Efficacy of low-dose spironolactone in subjects with resistant hypertension.

  2003cited by this paper

• Association of Post-Treatment Blood Pressure Levels with Incident Stroke in Patients with Primary Aldosteronism: A Retrospective Cohort Study.

  2026cites this paper
• New Therapies for the Management of Chronic Kidney Disease

  2025influential citation
• Study on the Association between Primary Aldosteronism and Cerebrovascular Disease

  2023cites this paper
• Vascular endothelial mineralocorticoid receptors and epithelial sodium channels in metabolic syndrome and related cardiovascular disease

  2023cites this paper
• Pharmacokinetic interactions of esaxerenone with amlodipine and digoxin in healthy Japanese subjects

  2020cites this paper
• The Endothelial Mineralocorticoid Receptor: Contributions to Sex Differences in Cardiovascular Disease.

  2019cites this paper
• Application of Organometallic Catalysts in API Synthesis

  2019cites this paper
• Role of Renin-Angiotensin-Aldosterone System Activation in Promoting Cardiovascular Fibrosis and Stiffness

  2018cites this paper
• Hypertension in the Kidney Transplant Recipient: Overview of Pathogenesis, Clinical Assessment, and Treatment

  2017cites this paper
• The role of mineralocorticoid receptor signaling in the cross-talk between adipose tissue and the vascular wall

  2017cites this paper
• Double Heck Route to a Dibenzoxepine and Convergent Suzuki Cross-Coupling Strategy for the Synthesis of an MR Antagonist

  2017cites this paper
• Hypertension in CKD Pregnancy: a Question of Cause and Effect (Cause or Effect? This Is the Question)

  2016cites this paper
• Renal denervation improves exercise blood pressure: insights from a randomized, sham-controlled trial

  2016cites this paper
• Vascular mineralocorticoid receptor regulates microRNA-155 to promote vasoconstriction and rising blood pressure with aging.

  2016cites this paper
• Consider mineralocorticoid receptor antagonists as add-on therapy in treatment-resistant hypertension

  2015cites this paper
• Consider mineralocorticoid receptor antagonists as add-on therapy in treatment-resistant hypertension

  2015influential citation
• Resistant Hypertension in Diabetes Mellitus

  2015cites this paper
• Complications and management of hyperkalemia: implications for the use of the novel cation exchangers zirconium cyclosilicate and patiromer

  2015cites this paper